A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD

References

• American Academy of Pediatrics; Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyper- activity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158–70
   Google Scholar
• Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev 2002;8:162–70
   PubMedGoogle Scholar
• Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention- deficit/hyperactivity disorder [American Academy of Child and Adolescent Psychiatry]. J Am Acad Child Adolesc Psychiatry 1997;36\(Suppl 10):85S–121S
   Google Scholar
• Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546–57
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41\(Suppl 2):26S–49S
   Google Scholar
• American Academy of Pediatrics; Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:1033–44
   Google Scholar
• Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 2001;11:59–67
   PubMed Web of Science ®Google Scholar
• Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 2002;156:504–11
   Google Scholar
• Swanson JM, Wigal S, Greenhill LL, et al. Analog classroom assessment of Adderall® in children with ADHD. J Am Acad Child Adolesc Psychiatry 1998;37:519–26
   PubMed Web of Science ®Google Scholar
• Pelham WE, Aronoff HR, Midlam JK, et al. A comparison of Ritalin and Adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics 1999a:103: e43. Available at: www.pediatrics.org/cgi/content/full/103/4/e43 [last accessed February 24, 2005]
   Google Scholar
• Pelham WE, Gnagy EM, Chronis AM, et al. A comparison of morning-only and morning/late afternoon Adderall to morning- only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 1999b;104:1300–11
   PubMed Web of Science ®Google Scholar
• Manos MJ, Short EJ, Findling RL. Differential effectiveness of methylphenidate and Adderall^® in school-age youths with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999;38:813–9
   Google Scholar
• Pliszka SR, Browne RG, Olvera RL, Wynne SK. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39:619–26
   PubMed Web of Science ®Google Scholar
• Ahmann PA, Theye FW, Berg R, Linquist AJ, Van Erem AJ, Campbell LR. Placebo-controlled evaluation of amphetamine mixture – dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics 2001;107:e10. Available at: www.pediatrics.org/cgi/content/full/107/1/e10 [last accessed February 24, 2005]
   Google Scholar
• Tulloch SJ, Zhang Y, McLean A, Wolf KN. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy 2002;22:1405–15
   PubMed Web of Science ®Google Scholar
• McCracken JT, Biederman J, Greenhill LL, et al. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry 2003;42:673–83
   PubMed Web of Science ®Google Scholar
• Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention- deficit/hyperactivity disorder. Pediatrics 2002;110:258–66
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington (DC): American Psychiatric Association Press; 1994
   Google Scholar
• Conners CK. Conners’ rating scales – revised: technical manual. North Tonawanda (NY): Multi-Health Systems; 1997
   Google Scholar
• Guy W, editor. Clinical Global Impressions (CGI). In: ECDEU assessment manual for psychopharmacology. Rockville (MD): US Dept of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch; 1976. p. 218–22
   Google Scholar
• SAS Institute. SAS/STAT software: changes and enhancements through release 6.12. Cary (NC): SAS Institute; 1997
   Google Scholar
• Sallee FR, Ambrosini PJ, Lopez FA, Shi L, Michaels MA. Quality of life and satisfaction/preference results from a trial of Adderall XR in children with ADHD in a community practice setting. J Outcomes Res 2004;8:27–49
   Google Scholar
• Pliszka SR, Lopez M, Crismon ML, et al. A feasibility study of the Children’s Medication Algorithm Project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry 2003;42:279–87
   PubMed Web of Science ®Google Scholar
• MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073–86
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996;35:1304–13
   PubMed Web of Science ®Google Scholar
• Marchetti A, Magar R, Lau H, et al. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. Clin Ther 2001;23:1904–21
   PubMed Web of Science ®Google Scholar
• Swanson J. Compliance with stimulants for attention-deficit/ hyperactivity disorder. Issues and approaches for improvement. CNS Drugs 2003;17:117–31
   Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296–310
   Google Scholar
• Horrigan JP, Kohli RR. The impact of dosing frequency on psychostimulant compliance in ADHD. Poster presented at: 42nd Annual New Drug Clinical Evaluation Unit (NCDEU) Meeting; Boca Raton (FL): June 11, 2002
   Google Scholar